Hem › Bröstcancer › Missouri › St. Louis

Kliniska studier för Bröstcancer i St. Louis, MO

64 studier för Bröstcancer söker deltagare vid platser i och runt St. Louis (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.

Officiell studietext (engelska)

Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →

The Vanguard Study: Testing a New Way to Screen for Cancer

RekryterarFriska volontärer välkomna

Washington University School of Medicine, St Louis

Ålder 45 till 75 · Alla kön · Uppdaterad 5 okt. 2026 · NCT06995898

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

RekryterarFas 3

Washington University School of Medicine- Siteman Cancer Center, St Louis

Ålder 18 och äldre · Alla kön · Uppdaterad 5 okt. 2026 · NCT06982521

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

RekryterarObservationsstudieFriska volontärer välkomna

Mercy Infusion Center - Chippewa, St Louis
Mercy Hospital South, St Louis
Missouri Baptist Medical Center, St Louis
och 4 fler

Ålder 40 till 75 · Alla kön · Uppdaterad 2 okt. 2026 · NCT05334069

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

RekryterarFas 2

Washington University, School of Medicine, St Louis

Ålder 18 och äldre · Alla kön · Uppdaterad 1 okt. 2026 · NCT06172478

A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer

RekryterarFas 2

Washington University School of Medicine, St Louis

Ålder 18 och äldre · Alla kön · Uppdaterad 1 okt. 2026 · NCT06369285

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

RekryterarFas 1

Washington University School of Medicine, St Louis

Ålder 18 och äldre · Alla kön · Uppdaterad 1 okt. 2026 · NCT06625775

An Investigational Study of BG-75202 Alone and in Combination With Other Therapeutic Agents in Adults With Advanced Solid Tumors

RekryterarFas 1

Washington University in St Louis, St Louis

Ålder 18 och äldre · Alla kön · Uppdaterad 28 sep. 2026 · NCT07222267

A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)

RekryterarFas 3

Washington University School of Medicine ( Site 0076), St Louis

Ålder 18 och äldre · Alla kön · Uppdaterad 25 sep. 2026 · NCT06312176

A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)

RekryterarFas 3

Research Site, St Louis

Ålder 18 och äldre · Alla kön · Uppdaterad 25 sep. 2026 · NCT06103864

ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer

RekryterarFas 2

Washington University School of Medicine- Siteman Cancer Center, St Louis

Ålder 18 och äldre · Alla kön · Uppdaterad 25 sep. 2026 · NCT07007559

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

RekryterarFas 3

Washington University Siteman Cancer Center ( Site 0031), St Louis

Ålder 18 och äldre · Alla kön · Uppdaterad 25 sep. 2026 · NCT06966700

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors

RekryterarFas 1/2

Local Institution - 0140, St Louis

Ålder 18 och äldre · Alla kön · Uppdaterad 23 sep. 2026 · NCT06618287

Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer

Rekryterar

Mercy Health - Sindelar Cancer Center, St Louis
Mercy Health - Pratt Cancer Center, St Louis

Ålder 18 och äldre · Alla kön · Uppdaterad 23 sep. 2026 · NCT07214532

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

RekryterarFas 1

Washington University, St Louis

Ålder 18 och äldre · Alla kön · Uppdaterad 22 sep. 2026 · NCT07114601

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

RekryterarFas 1

Washington University School of Medicine in St. Louis, St Louis

Ålder 18 och äldre · Alla kön · Uppdaterad 22 sep. 2026 · NCT07213791

A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer

RekryterarFas 2

Washington University School of Medicine, St Louis

Ålder 18 och äldre · Kvinnor · Uppdaterad 22 sep. 2026 · NCT07287098

A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer

RekryterarFas 1/2

Washington University School of Medicine, St Louis

Ålder 18 och äldre · Alla kön · Uppdaterad 17 sep. 2026 · NCT06827236

ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer

RekryterarFas 3

Cancer Care Specialists of Illinois, O'Fallon · 16 mi bort

Ålder 18 och äldre · Alla kön · Uppdaterad 17 sep. 2026 · NCT07173751

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

RekryterarFas 1/2

Washington Univ. School of Medicine, St Louis

Ålder 18 och äldre · Alla kön · Uppdaterad 17 sep. 2026 · NCT07109726

Precision Supplemental Imaging in Women With Dense Breasts

RekryterarFriska volontärer välkomna

Washington University School of Medicine, St Louis

Ålder 25 till 55 · Kvinnor · Uppdaterad 16 sep. 2026 · NCT07277738

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

RekryterarFas 3

Siteman Cancer Center, St Louis

Ålder 18 och äldre · Alla kön · Uppdaterad 15 sep. 2026 · NCT06492616

A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies

RekryterarFas 1/2

Research Site, St Louis

Ålder 18 och äldre · Alla kön · Uppdaterad 11 sep. 2026 · NCT05123482

A Phase 1/1b Study of IAM1363 in HER2 Cancers

RekryterarFas 1

Washington University School of Medicine, St Louis

Ålder 18 och äldre · Alla kön · Uppdaterad 9 sep. 2026 · NCT06253871

A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors

RekryterarFas 1

Washington University School of Medicine, St Louis

Ålder 18 och äldre · Alla kön · Uppdaterad 9 sep. 2026 · NCT06440005

A Study of LOXO-783 in Patients With Breast Cancer/Other Solid Tumors

RekryterarFas 1

Washington University Medical School, St Louis

Ålder 18 och äldre · Alla kön · Uppdaterad 8 sep. 2026 · NCT05307705

A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer

RekryterarFas 1/2

Washington University Siteman Cancer Center, St Louis

Ålder 18 och äldre · Alla kön · Uppdaterad 8 sep. 2026 · NCT07100106

A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer

RekryterarFas 3

Cancer Care Specialists of Central Illinois, O'Fallon · 16 mi bort

Ålder 18 och äldre · Alla kön · Uppdaterad 3 sep. 2026 · NCT06790693

Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies

RekryterarObservationsstudie

Cancer Care Specialist of Illinois, O'Fallon · 16 mi bort

Ålder 18 till 99 · Alla kön · Uppdaterad 3 sep. 2026 · NCT07211178

Ovarian-Sparing Adaptive Radiotherapy in Young Adult Women

RekryterarObservationsstudie

Washington University School of Medicine, St Louis

Ålder 18 till 50 · Kvinnor · Uppdaterad 2 sep. 2026 · NCT06904365

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

RekryterarFas 3

Mercy Infusion Center - Chippewa, St Louis
Washington University School of Medicine, St Louis
Mercy Hospital South, St Louis
och 9 fler

Ålder 18 till 60 · Kvinnor · Uppdaterad 2 sep. 2026 · NCT05879926

A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors

RekryterarFas 1

Washington University, St Louis

Ålder 18 och äldre · Alla kön · Uppdaterad 28 aug. 2026 · NCT07029399

Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and in Patients With Other Advanced Solid Tumors

RekryterarFas 1/2

WA Uni School Of Med, St Louis

Ålder 18 till 100 · Alla kön · Uppdaterad 27 aug. 2026 · NCT06726148

A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors

RekryterarFas 1

Washington University School of Medicine - Siteman Cancer Center, St Louis

Ålder 18 och äldre · Alla kön · Uppdaterad 26 aug. 2026 · NCT07383506

A Phase 1 Study of LNCB74 in Advanced Solid Tumors

RekryterarFas 1

Washington University, Siteman Cancer Center, St Louis

Ålder 18 och äldre · Alla kön · Uppdaterad 21 aug. 2026 · NCT06774963

Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial

RekryterarFas 3

Washington University School of Medicine, St Louis
Mercy Hospital South, St Louis
Siteman Cancer Center-South County, St Louis
och 4 fler

Ålder 18 och äldre · Alla kön · Uppdaterad 17 aug. 2026 · NCT06500481

FIH Study of RGT-419B Alone and With Endocrine Therapy in HR-Positive, HER2-Negative Advanced/Metastatic Breast Cancer

RekryterarFas 1

Washington University School of Medicine, St Louis

Ålder 18 och äldre · Alla kön · Uppdaterad 12 aug. 2026 · NCT05304962

Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects

RekryterarFas 3

Siteman Cancer Center - Washington University Medical Campus, St Louis

Ålder 18 till 100 · Alla kön · Uppdaterad 6 aug. 2026 · NCT05232916

IDOV-Immune for Advanced Solid Tumors

RekryterarFas 1

Washington University School of Medicine, St Louis

Ålder 18 och äldre · Alla kön · Uppdaterad 5 aug. 2026 · NCT06910657

E-Mindfulness Approaches for Living After Breast Cancer

RekryterarFas 3

Mercy Hospital South, St Louis
Missouri Baptist Medical Center, St Louis
Cancer Care Center of O'Fallon, O'Fallon · 16 mi bort

Ålder 18 till 50 · Alla kön · Uppdaterad 4 aug. 2026 · NCT06748222

Endocrine Treatment Alone for Elderly Patients With Estrogen Receptor Positive Operable Breast Cancer and Low Recurrence Score

RekryterarFas 2

Washington University School of Medicine, St Louis

Ålder 70 och äldre · Kvinnor · Uppdaterad 27 juli 2026 · NCT02476786

Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial

RekryterarFas 2

Washington University School of Medicine, St Louis

Ålder 18 till 55 · Kvinnor · Uppdaterad 27 juli 2026 · NCT06184750

Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors

RekryterarFas 1

Investigative Site #110, St Louis

Ålder 18 och äldre · Alla kön · Uppdaterad 23 juli 2026 · NCT06545942

Testing the Safety of the Combination of Anti-Cancer Drugs CX-5461 (Pidnarulex) and Trastuzumab Deruxtecan (T-DXd) for Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Solid Tumors and Breast Cancer

RekryterarFas 1

Washington University School of Medicine, St Louis

Ålder 18 och äldre · Alla kön · Uppdaterad 13 juli 2026 · NCT07137416

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

RekryterarFas 1/2

Washington University, St Louis

Ålder 18 och äldre · Alla kön · Uppdaterad 7 juli 2026 · NCT05768139

Treatment Monitoring of Patients Receiving CDK 4/6 Inhibitors for Hormone Receptor (HR) Positive, HER2 Negative Metastatic Breast Cancer (MBC) With or Without the Addition of DiviTum® Serum Thymidine Kinase 1 (TK1) Activity Testing

Rekryterar

Washington University School of Medicine, St Louis

Ålder 18 och äldre · Alla kön · Uppdaterad 6 juli 2026 · NCT04968964

Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation

RekryterarFas 3

Washington University School of Medicine, St Louis

Ålder 18 och äldre · Alla kön · Uppdaterad 22 juni 2026 · NCT05696626

ChatGPT & Surgeon Synergy: Redefining Breast Reconstruction Consultations for Enhanced Patient Engagement and Satisfaction

Rekryterar

Washington University School of Medicine, St Louis

Ålder 18 och äldre · Alla kön · Uppdaterad 10 juni 2026 · NCT06981208

Phase 3 Study of Gedatolisib as First-Line Treatment for Patients With HR-Positive, HER2-Negative Advanced Breast Cancer (VIKTORIA-2)

RekryterarFas 3

Washington University School of Medicine in Saint Louis, St Louis

Ålder 18 och äldre · Alla kön · Uppdaterad 18 maj 2026 · NCT06757634

COOL-IT-PRO: Cryoablation of Breast Cancer in Non-surgical Patients

RekryterarObservationsstudie

Washington University School of Medicine, St Louis

Ålder 18 och äldre · Alla kön · Uppdaterad 7 maj 2026 · NCT05972343

A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.

RekryterarFas 3

Siteman Cancer Center, St Louis
Siteman Cancer Center - North County, Florissant · 13 mi bort
Memorial Hospital., Shiloh · 17 mi bort

Ålder 18 och äldre · Alla kön · Uppdaterad 6 maj 2026 · NCT07062965

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

RekryterarFas 3

Mercy Hospital South, St Louis
Missouri Baptist Medical Center, St Louis
Mercy Hospital Saint Louis, St Louis
och 3 fler

Ålder 50 till 70 · Alla kön · Uppdaterad 23 apr. 2026 · NCT04852887

Zunsemetinib in Combination With Capecitabine in Patients With Hormone Receptor-Positive and HER2-Negative Metastatic Breast Cancer With Bone Metastasis

RekryterarFas 1/2

Washington University School of Medicine, St Louis

Ålder 18 och äldre · Alla kön · Uppdaterad 20 apr. 2026 · NCT06374459

NeoTAILOR: ABiomarker-directed Approach to Guide Neoadjuvant Therapy for Patients With Stage II/III ER-positive, HER2-negative Breast Cancer

RekryterarFas 2

Washington University School of Medicine, St Louis

Ålder 18 och äldre · Kvinnor · Uppdaterad 13 apr. 2026 · NCT05837455

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

RekryterarObservationsstudie

Mercy Hospital South, St Louis
Missouri Baptist Medical Center, St Louis
Mercy Hospital Saint Louis, St Louis
och 4 fler

Ålder 18 och äldre · Alla kön · Uppdaterad 17 mars 2026 · NCT06418204

Cryoablation vs Lumpectomy in T1 Breast Cancers

Rekryterar

Washington University School of Medicine, St Louis

Ålder 50 och äldre · Kvinnor · Uppdaterad 27 feb. 2026 · NCT05505643

Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors

RekryterarObservationsstudieFriska volontärer välkomna

Washington University School of Medicine, St Louis

Ålder 18 och äldre · Alla kön · Uppdaterad 20 feb. 2026 · NCT04354064

Ultra-Hypofractionated vs. Hypofractionated Radiation for Node-Positive Breast Cancer

RekryterarFas 2

Washington University School of Medicine, St Louis

Ålder 18 och äldre · Kvinnor · Uppdaterad 9 jan. 2026 · NCT06559540

BettER: Biomarker Driven Early Therapeutic Selection in Patients With HR+ HER2- Metastatic or Unresectable Breast Cancer

Rekryterar

Washington University School of Medicine, St Louis

Ålder 18 och äldre · Alla kön · Uppdaterad 17 dec. 2025 · NCT05977036

Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells

RekryterarObservationsstudie

Washington University School of Medicine, St Louis

Ålder 18 och äldre · Alla kön · Uppdaterad 28 nov. 2025 · NCT00353483

WashU DIEP Flap Video and Patient Understanding Improvement

Rekryterar

Washington University School of Medicine, St Louis

Ålder 18 och äldre · Kvinnor · Uppdaterad 24 nov. 2025 · NCT06864754

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

RekryterarObservationsstudie

Massive Bio SYNERGY-AI site, St Louis

Alla åldrar · Alla kön · Uppdaterad 28 okt. 2025 · NCT03452774

S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity

RekryterarFas 3

Saint Louis Cancer and Breast Institute-South City, St Louis
Mercy Hospital South, St Louis
Missouri Baptist Medical Center, St Louis
och 2 fler

Ålder 18 och äldre · Alla kön · Uppdaterad 8 okt. 2025 · NCT03418961

First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer

RekryterarFas 1

Washington University School of Medicine St. Louis, St Louis

Ålder 18 och äldre · Alla kön · Uppdaterad 22 sep. 2025 · NCT05216432

MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles

RekryterarObservationsstudie

Washington University School of Medicine, St Louis

Ålder 18 och äldre · Alla kön · Uppdaterad 20 aug. 2025 · NCT03053193

Bröstcancer-studier i andra städer

Andra studier i St. Louis

Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.